Viatris Inc. Common Stock (VTRS)
$
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
About
Business overview of Viatris Inc. Common Stock (VTRS)
Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. Remaining 60% of sales is derived from its portfolio of legacy products which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.
Key Insights
Critical company metrics and information
Share Price
$12.95Market Cap
$15.45 BillionTotal Outstanding Shares
1.19 Billion SharesTotal Employees
38,000Dividend
$0.12 Per Share QuarterlyIPO Date
April 14, 1986SIC Description
Pharmaceutical PreparationsHomepage
https://www.viatris.com
Historical Stock Splits
Execution Date | Split Amount |
---|---|
No Historical Stock Splits |
Cash Flow Statement
July 1, 2024 to September 30, 2024
Metric | Value |
---|---|
Net Cash Flow, Continuing | $937.70 Million |
Net Cash Flow From Investing Activities, Continuing | $1.75 Billion |
Net Cash Flow From Financing Activities, Continuing | $-1.64 Billion |
Net Cash Flow From Investing Activities | $1.75 Billion |
Net Cash Flow From Operating Activities | $826.50 Million |
Net Cash Flow From Financing Activities | $-1.64 Billion |
Net Cash Flow | $961.60 Million |
Net Cash Flow From Operating Activities, Continuing | $826.50 Million |
Exchange Gains/Losses | $23.90 Million |
Income Statement
July 1, 2024 to September 30, 2024
Metric | Value |
---|---|
Diluted Earnings Per Share | $0.08 |
Operating Expenses | $1.23 Billion |
Benefits Costs and Expenses | $3.66 Billion |
Income Tax Expense/Benefit | $-4.30 Million |
Operating Income/Loss | $225.90 Million |
Income/Loss From Continuing Operations Before Tax | $90.50 Million |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
Income Tax Expense/Benefit, Deferred | $-312.40 Million |
Net Income/Loss Available To Common Stockholders, Basic | $94.80 Million |
Costs And Expenses | $3.66 Billion |
Preferred Stock Dividends And Other Adjustments | $0.00 |
Cost Of Revenue | $2.29 Billion |
Revenues | $3.75 Billion |
Other Operating Expenses | $31.50 Million |
Interest Expense, Operating | $145.60 Million |
Net Income/Loss | $94.80 Million |
Basic Earnings Per Share | $0.08 |
Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
Research and Development | $198.40 Million |
Gross Profit | $1.46 Billion |
Selling, General, and Administrative Expenses | $1.00 Billion |
Diluted Average Shares | $1.20 Billion |
Common Stock Dividends | $0.12 |
Net Income/Loss Attributable To Parent | $94.80 Million |
Basic Average Shares | $1.19 Billion |
Income/Loss From Continuing Operations After Tax | $94.80 Million |
Balance Sheet
July 1, 2024 to September 30, 2024
Metric | Value |
---|---|
Wages | $668.20 Million |
Noncurrent Assets | $33.45 Billion |
Current Assets | $11.31 Billion |
Liabilities | $24.96 Billion |
Noncurrent Liabilities | $17.45 Billion |
Assets | $44.75 Billion |
Inventory | $4.08 Billion |
Prepaid Expenses | $134.50 Million |
Intangible Assets | $17.98 Billion |
Other Current Liabilities | $6.84 Billion |
Other Current Assets | $4.23 Billion |
Liabilities And Equity | $44.75 Billion |
Current Liabilities | $7.51 Billion |
Equity Attributable To Parent | $19.79 Billion |
Accounts Receivable | $2.86 Billion |
Other Non-current Assets | $12.79 Billion |
Fixed Assets | $2.68 Billion |
Equity Attributable To Noncontrolling Interest | $0.00 |
Equity | $19.79 Billion |
Historical Dividends
Current dividend: $0.12 Per Share Quarterly
Announcement Date | Payment Date | Record Date | Amount | Frequency |
---|---|---|---|---|
Nov 4, 2024 | Dec 13, 2024 | Nov 22, 2024 | $0.12 | Quarterly |
Aug 5, 2024 | Sep 13, 2024 | Aug 23, 2024 | $0.12 | Quarterly |
May 6, 2024 | Jun 14, 2024 | May 24, 2024 | $0.12 | Quarterly |
Feb 26, 2024 | Mar 18, 2024 | Mar 11, 2024 | $0.12 | Quarterly |
Nov 7, 2023 | Dec 15, 2023 | Nov 24, 2023 | $0.12 | Quarterly |
Aug 4, 2023 | Sep 15, 2023 | Aug 24, 2023 | $0.12 | Quarterly |
May 5, 2023 | Jun 16, 2023 | May 24, 2023 | $0.12 | Quarterly |
Feb 24, 2023 | Mar 17, 2023 | Mar 9, 2023 | $0.12 | Quarterly |
Nov 7, 2022 | Dec 16, 2022 | Nov 23, 2022 | $0.12 | Quarterly |
Aug 4, 2022 | Sep 16, 2022 | Aug 24, 2022 | $0.12 | Quarterly |
May 5, 2022 | Jun 16, 2022 | May 24, 2022 | $0.12 | Quarterly |
Jan 6, 2022 | Mar 16, 2022 | Feb 24, 2022 | $0.12 | Quarterly |
Nov 8, 2021 | Dec 16, 2021 | Nov 23, 2021 | $0.11 | Quarterly |
Aug 9, 2021 | Sep 16, 2021 | Aug 24, 2021 | $0.11 | Quarterly |
May 10, 2021 | Jun 16, 2021 | May 24, 2021 | $0.11 | Quarterly |
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
ⓒ 2024 Financhle. All Rights Reserved.